OMERS Ventures adds journalist Farr to invest in healthtech deals

Christina Farr joins the venture firm after more than three years as a healthtech reporter for CNBC, based in Silicon Valley.

Christina Farr announced on Twitter this afternoon that she has joined OMERS Ventures as a principal to invest in healthtech.

“I’ll be meeting with founders, diligencing deals, and supporting our existing portfolio,” she wrote in a blog post that doubles as her newly-launched healthtech newsletter.

Since April 2017, Farr has been a healthtech reporter at CNBC, where she covered the pandemic and other healthtech start-up trends. Her reporting included hosting a “guinea pig” video series for CNBC in which she tried out wearable devices, tracked various aspects of her health with the latest tech and experimented with fad diets, including keto and intermittent fasting.

Prior to CNBC, she covered health and tech at Fast Company.

OMERS Ventures is the venture capital arm of Canadian pension fund Ontario Municipal Employees Retirement System. The firm has expanded its presence in the San Francisco Bay Area in recent years, where Farr is based, having opened an office in Palo Alto nearly two years ago, led by managing partner Michael Yang.

Earlier this year, OMERS Ventures announced a $750 million transatlantic fund to invest in Canada, the US, the UK and the rest of Europe in sectors including healthtech. A recent deal in the space includes Berlin-based Vara, a provider of breast cancer screening software. The company raised $7 million in Series A funding, with OMERS Ventures leading the round.